Nektar Therapeutics (NKTR) Return on Capital Employed Growth (1y) (2012 - 2026)
Nektar Therapeutics (NKTR) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -3,457.00 |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | 2,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,566.00 |
| Dec 31, 2025 | -1,601.00 |
| Sep 30, 2025 | 716.00 |
| Jun 30, 2025 | -1,041.00 |
| Mar 31, 2025 | -696.00 |
| Dec 31, 2024 | 2,846.00 |
| Sep 30, 2024 | 861.00 |
| Jun 30, 2024 | 882.00 |
| Mar 31, 2024 | 2,072.00 |
| Dec 31, 2023 | -1,597.00 |
| Sep 30, 2023 | -872.00 |
| Jun 30, 2023 | -202.00 |
| Mar 31, 2023 | -2,147.00 |
| Dec 31, 2022 | -1,540.00 |
| Sep 30, 2022 | -2,172.00 |
| Jun 30, 2022 | -2,539.00 |
| Mar 31, 2022 | -1,778.00 |
| Dec 31, 2021 | -992.00 |
| Sep 30, 2021 | -773.00 |
| Jun 30, 2021 | -783.00 |